Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aciclovir for HSV-2 Meningitis (AMEN)
NCT05452928Phase 4Not yet recruiting
- Start
- Jan 2027
- Primary completion
- Dec 2031
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
A Phase 4 trial of aciclovir in herpes simplex meningitis (HSM). Planned start Jan 2027; status: not yet recruiting.
02
Drugs
aciclovir
03
Conditions
herpes simplex meningitis (HSM)
Beyond the preview
Go deeper on NCT05452928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05452928.